Utility of C - reactive protein as a Novel Prognostic Marker in Patients with Carcinoma Prostate Undergoing Androgen Deprivation Therapy

Journal Title: IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) - Year 2017, Vol 16, Issue 3

Abstract

Introduction and objectives: There is increasing recognition that systemic inflammation is associated with progression and reduced survival of prostate cancer patients. C-reactive protein (CRP) is an inflammatory marker that has been evaluated as a reflection of the same. Our aim was to study the prognostic implications of pre-treatment CRP values with regard to PSA response, disease progression and short term survival in patients with carcinoma prostate undergoing androgen deprivation therapy (ADT). Patients and methods: 86 patients with prostate cancer were subjected to measurement of CRP levels at time of diagnosis.PSA levels, Gleason score, haemoglobin, S.albumin were determined for all patients. Patients were grouped according to age, Gleason grade, PSA levels and presence of bone metastatic disease. They were followed up prospectively at preset regular intervals post ADT with relevant investigations for 12 months. Results: CRP values were significantly elevated in patients with higher PSA (1.78 vs 9.81 for PSA />20ng/dl), bone metastases (18.68 vs 6.06 for no mets), and higher gleason grade.Quartiles of CRP were: 0–2.0, 2.1–6.9, 7.0–15.5, and15.6–78 mg/L On follow up, CRP was a predictive of PSA response ( achieved in > 80% for patients with lowest CRP quartile compared to response in < 25% in highest quartile). In the cohort of patients with metastatic disease- CRP, low albumin levels, gleason score were prognostic factors for short term survival at 1 year. On regression analysis CRP remained an independent prognostic factor HR 1.49 inCRP (p = 0.023). Conclusion: We have found that rise in CRP level is significantly associated with an aggressive tumor phenotype at the time of diagnosis.CRP can be predictive of PSA response to therapy. Also, CRP is a costeffective test that can be used as one of the markers to risk-stratify men with advanced prostate cancer.

Authors and Affiliations

Dineshan K M, Aditya Shenoy, Felix Cardoza

Keywords

Related Articles

Prevalence of Malaria in Febrile Under Five Children in Port Harcourt, Nigeria

Background: Malaria remains the commonest tropical disease in the world characterised by periodic bouts of severe chills and high fever. It is one of the most significant public health problems in Nigeria leading to sign...

A cross-sectional study of most prevalent uropathogens in urinary tract infection in relation to gender and antibiotic sensitivity.

Introduction: Knowledge of most prevalent uropathogens in a geographic area is vital for treating physicians of that area to make a better choice of empirical antibiotics. In addition, understanding how the most prevalen...

A Study on Usage of Different Medications among Medical Students during Their Examination Days

Background: Some of the medical students are using different medications during their examination days to perorm well in the examinations. There is a need to identify what medications they are usingand take certain measu...

Comparision of Healing of Periapical Lesion with Different Intracanal Medicament Using Mineral Trioxide Aggregate as Apical Barrier

Twelve maxillary central incisors in patients aged between 15 to 30 years who suffered a traumatic injury were selected. All patients presented with incomplete development of the root apex. Conventional access cavity was...

Preterm Labour, Pprom, Prom And Neonatal Outcomes Associated With Vaginal Infection: A Prospective Study

Purpose 1. To find the incidence of preterm labor, preterm premature rupture of membranes (PPROM) and premature rupture of membranes (PROM) in relation with vaginal infection. 2. Use of high vaginal swab to detect the or...

Download PDF file
  • EP ID EP592490
  • DOI 10.9790/0853-1603020713
  • Views 39
  • Downloads 0

How To Cite

Dineshan K M, Aditya Shenoy, Felix Cardoza (2017). Utility of C - reactive protein as a Novel Prognostic Marker in Patients with Carcinoma Prostate Undergoing Androgen Deprivation Therapy. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), 16(3), 7-13. https://europub.co.uk/articles/-A-592490